Somerset NHS Foundation Trust has joined a national campaign to recruit people from Black communities to a health research biobank. The initiative aims to correct the historic underrepresentation of Black populations in clinical studies and in the collection of medical data, a gap that researchers say affects the quality of care patients receive.

The programme is called the Improving Black Health Outcomes (IBHO) BioResource. Volunteers provide health information and a biological sample, and both are held in a central biobank. Approved researchers can then draw on the collection for future medical studies. Somerset's involvement adds a recruitment site in the south west of England.

Kate James, the Trust's medical research lead, says the problem lies in the evidence on which healthcare is built. Standard medicines and treatments have historically been developed using study populations that lacked racial diversity. Guidance written from that evidence reflects the people who took part in the research, and those participants did not represent the full range of patients the NHS serves.

The consequences are practical. Biological differences can influence how an individual processes a medication and how strongly they respond to it. A drug tested mainly on one group may behave differently in another, and clinicians treating that second group have less data to guide the choice of treatment or the dose. Diverse research cohorts are therefore regarded as essential if treatments are to be safe and effective for everyone who receives them.

The study is open to anyone aged 16 or over from a Black African, Black Caribbean or Black British background. A separate route exists for people with a confirmed diagnosis of sickle cell disease or thalassaemia, who may take part whatever their ethnic background. Both conditions are inherited disorders of the blood. Including these participants allows the collection to support research into the conditions themselves as well as into wider questions of health in Black communities.

Taking part involves two steps. Volunteers complete a health questionnaire and then give a sample of either blood or sputum. Samples are anonymised before storage, which means researchers using them cannot trace the material back to an individual. They are kept securely within the central biobank, where they remain available for projects that have yet to be designed. This long-term purpose is a defining feature of a biobank. A sample collected today could provide valuable data for research undertaken years later.

Sample collection takes place at a mobile research unit based at Musgrove Park Hospital in Taunton. The unit offers flexible appointments, so volunteers can choose a time that suits them. Hospital sites can be difficult to reach during working hours, and appointment flexibility is one practical way of widening access to research for people who might otherwise find participation hard to arrange.

The gap in representation is long-standing, and a single recruitment site will not close it. The biobank's value will depend on how many people come forward across the country. A larger and more varied collection gives researchers a stronger base for studies that examine how conditions and treatments affect different groups, and it gives clinicians better evidence when they make decisions for individual patients.

For Somerset, the immediate task is recruitment. Eligible residents can take part through the unit at Musgrove Park Hospital, where the questionnaire and sample collection are completed in a single visit. The Trust has framed the project as a contribution to a national evidence base that it hopes will serve patients from every background more reliably than the one currently in use.

‍